Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study

Division of Cardiology, University of Maryland School of Medicine, Baltimore 21201-1595, USA. mmiller@heart.ab.umd.edu

OBJECTIVES: This study sought to evaluate long-term predictors of coronary events in men and women with arteriographically defined coronary artery disease (CAD). BACKGROUND: There is conflicting evidence of the role of triglycerides (TGs) as a prognosticator of CAD, and no studies have examined the long-term outcome of "normal" levels in predicting new coronary events. METHODS: This was a retrospective cohort study that evaluated 740 consecutive patients presenting for diagnostic coronary arteriography between 1977 and 1978. Beginning in 1988, patients with arteriographic CAD (n=350) were recontacted and asked to complete detailed medical questionnaires. Case and control patients were stratified by development of new coronary events, including death from ischemic heart disease, nonfatal myocardial infarction and revascularization. RESULTS: There were 199 events during the 18-year follow-up period. The mean high density lipoprotein cholesterol (HDL-C) was significantly lower (35 vs. 39 mg/dl; p=0.002) and TGs higher (160 vs. 137 mg/dl; p=0.03) in case patients than in control patients; After adjusting for age, gender and beta-adrenergic blocking agent use, multiple logistic regression analysis revealed the following independent predictors of CAD events: diabetes mellitus (relative risk [RR] 2.1, 95% confidence interval [CI] 1.4% to 3.1%), HDL-C <35 mg/dl (RR 1.5, 95% CI 1.1% to 2.00) and TGs >100 mg/dl (RR 1.5, 95% CI 1.1% to 2.1%). A Kaplan-Meier analysis revealed significantly reduced survival from CAD events in patients with baseline TG levels > or = 100 mg/dl compared with TG levels <100 mg/dl (p=0.008). CONCLUSIONS: TG levels previously considered "normal" are predictive of new CAD events. The cutpoints established by the National Cholesterol Education Program for elevated TGs (>200 mg/dl) may need to be refined.

This article has been cited by other articles:

				M. Miller, N. J. Stone, C. Ballantyne, V. Bittner, M. H. Criqui, H. N. Ginsberg, A. C. Goldberg, W. J. Howard, M. S. Jacobson, P. M. Kris-Etherton, et al. Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association Circulation, May 24, 2011; 123(20): 2292 - 2333. [Full Text] [PDF]

				G. R. Hajer, T. W. van Haeften, and F. L.J. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur. Heart J., December 2, 2008; 29(24): 2959 - 2971. [Abstract] [Full Text] [PDF]

				G. Reyes, K. Yasunaga, E. Rothenstein, W. Karmally, R. Ramakrishnan, S. Holleran, and H. N. Ginsberg Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance J. Lipid Res., March 1, 2008; 49(3): 670 - 678. [Abstract] [Full Text] [PDF]

				M. Miller, C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, E. Braunwald, and for the PROVE IT-TIMI 22 Investigators Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial J. Am. Coll. Cardiol., February 19, 2008; 51(7): 724 - 730. [Abstract] [Full Text] [PDF]

				A. Garg and V. Simha Update on Dyslipidemia J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1581 - 1589. [Abstract] [Full Text] [PDF]

				M. J. Zibaeenezhad, S. J. Shamsnia, and M. Khorasani Walnut Consumption in Hyperlipidemic Patients Angiology, September 1, 2005; 56(5): 581 - 583. [Abstract] [PDF]

				P. N. Hopkins, L. L. Wu, S. C. Hunt, and E. A. Brinton Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1003 - 1012. [Abstract] [Full Text] [PDF]

				A. Slyper, J. Jurva, J. Pleuss, R. Hoffmann, and D. Gutterman Influence of glycemic load on HDL cholesterol in youth Am J Clin Nutr, February 1, 2005; 81(2): 376 - 379. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Dyslipidemia and the Metabolic Syndrome Diabetes Care, December 1, 2004; 27(12): 3009 - 3016. [Full Text] [PDF]

				Y. W. Aude, A. S. Agatston, F. Lopez-Jimenez, E. H. Lieberman, Marie Almon, M. Hansen, G. Rojas, G. A. Lamas, and C. H. Hennekens The National Cholesterol Education Program Diet vs a Diet Lower in Carbohydrates and Higher in Protein and Monounsaturated Fat: A Randomized Trial Arch Intern Med, October 25, 2004; 164(19): 2141 - 2146. [Abstract] [Full Text] [PDF]

				Y. Liao, S. Kwon, S. Shaughnessy, P. Wallace, A. Hutto, A. J. Jenkins, R. L. Klein, and W. T. Garvey Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia Diabetes Care, April 1, 2004; 27(4): 978 - 983. [Abstract] [Full Text] [PDF]

				X. Prieur, H. Coste, and J. C. Rodriguez The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-{alpha} and Contains a Novel Farnesoid X-activated Receptor Response Element J. Biol. Chem., July 3, 2003; 278(28): 25468 - 25480. [Abstract] [Full Text] [PDF]

				M.J. Zibaeenezhad, M. Rezaiezadeh, A. Mowla, S.M.T. Ayatollahi, and M.R. Panjehshahin Antihypertriglyceridemic Effect of Walnut Oil Angiology, July 1, 2003; 54(4): 411 - 414. [Abstract] [PDF]

				H. Hiyoshi, M. Yanagimachi, M. Ito, N. Yasuda, T. Okada, H. Ikuta, D. Shinmyo, K. Tanaka, N. Kurusu, I. Yoshida, et al. Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes J. Lipid Res., January 1, 2003; 44(1): 128 - 135. [Abstract] [Full Text] [PDF]

				V. Stangl, G. Baumann, and K. Stangl Coronary atherogenic risk factors in women Eur. Heart J., November 2, 2002; 23(22): 1738 - 1752. [Full Text] [PDF]

				H. Coste and J. C. Rodriguez Orphan Nuclear Hormone Receptor Rev-erbalpha Regulates the Human Apolipoprotein CIII Promoter J. Biol. Chem., July 19, 2002; 277(30): 27120 - 27129. [Abstract] [Full Text] [PDF]

				E. J. Schaefer, J. R. McNamara, P. K. Shah, K. Nakajima, L. A. Cupples, J. M. Ordovas, and P. W.F. Wilson Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framingham Offspring Study Diabetes Care, June 1, 2002; 25(6): 989 - 994. [Abstract] [Full Text] [PDF]

				S. H. McGladdery and J. J. Frohlich Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy J. Lipid Res., November 1, 2001; 42(11): 1905 - 1912. [Abstract] [Full Text] [PDF]

				W. Wang, A. Basinger, R. A. Neese, B. Shane, S.-A Myong, M. Christiansen, and M. K. Hellerstein Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E540 - E547. [Abstract] [Full Text] [PDF]

				W. S. Harris and J. H. O'Keefe Jr Invited Review: Cardioprotective Effects of {omega}-3 Fatty Acids Nutr Clin Pract, February 1, 2001; 16(1): 6 - 12. [Abstract] [PDF]

				R. H. Knopp Introduction: Low-Saturated Fat, High-Carbohydrate Diets: Effects on Triglyceride and LDL Synthesis, the LDL Receptor, and Cardiovascular Disease Risk Exp Biol Med, December 1, 2000; 225(3): 175 - 177. [Full Text] [PDF]

				R. H. Knopp, B. Retzlaff, C. Walden, B. Fish, B. Buck, and B. McCann One-Year Effects of Increasingly Fat-Restricted, Carbohydrate-Enriched Diets on Lipoprotein Levels in Free-Living Subjects Exp Biol Med, December 1, 2000; 225(3): 191 - 199. [Abstract] [Full Text] [PDF]

				A. Oberman Hypertriglyceridemia and Coronary Heart Disease J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2098 - 2105. [Full Text]

				R. J. Havel and P. H. Frost The Role of Non-High-Density Lipoprotein-Cholesterol in Evaluation and Treatment of Lipid Disorders J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2105 - 2108. [Full Text]

				B de Lignieres and S Silberstein Pharmacodynamics of Oestrogens and Progestogens Cephalalgia, April 1, 2000; 20(3): 200 - 207. [Abstract] [Full Text] [PDF]

				P. Benlian, C. Cansier, G. Hennache, O. Khallouf, P. Bayer, F. Duron, F. Carrat, R. Couderc, O. Chazouilleres, J. Bardet, et al. Comparison of a New Method for the Direct and Simultaneous Assessment of LDL- and HDL-Cholesterol with Ultracentrifugation and Established Methods Clin. Chem., April 1, 2000; 46(4): 493 - 505. [Abstract] [Full Text] [PDF]

				X. Garcia-Moll, F. Coccolo, D. Cole, and J. C. Kaski Serum neopterin and complex stenosis morphology in patients with unstable angina J. Am. Coll. Cardiol., March 15, 2000; 35(4): 956 - 962. [Abstract] [Full Text] [PDF]

				S. M. Grundy, T. Bazzarre, J. Cleeman, R. B. D Agostino Sr, M. Hill, N. Houston-Miller, W. B. Kannel, R. Krauss, H. M. Krumholz, R. M. Lauer, et al. Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I Circulation, January 4, 2000; 101(1): e3 - e11. [Full Text] [PDF]

				P. N. Herbert, M. Miller, S. A. Lear, and D. Ornish Effect of Lifestyle Changes on Coronary Heart Disease JAMA, July 14, 1999; 282(2): 130 - 132. [Full Text] [PDF]

				E. A. Enas, B. Lamarche, G. R. Dagenais, and J.-P. Despres Triglycerides and Small, Dense Low-Density Lipoprotein JAMA, December 16, 1998; 280(23): 1990 - 1991. [Full Text] [PDF]